Daily non-political popular news in brief.

Improved meningitis vaccine for Africa could signal eventual end to to deadly scourge

The Meningitis Vaccine Project today released new data on the performance of a meningitis vaccine in West African children, suggesting that the new vaccine -- expected to sell initially for 40 US cents a dose -- will be much more effective in protecting African children and their communities than any vaccine currently on the market in the region.

Read more »

Keywords: improved, meningitis, vaccine, africa, signal, eventual, deadly, scourge, meningiti

« Previous | Next »

Similar news on "Improved meningitis vaccine for Africa could signal eventual end to to deadly scourge":

1. Poxvirus' ability to hide from the immune system may aid vaccine design
   11-15-2007 · EurekAlert!
   The cowpox virus, a much milder cousin of the deadly smallpox virus, can keep infected host cells from warning the immune system that they have been compromised, researchers at Washington University School of Medicine in St. Louis have found. The scientists also showed that more virulent poxviruses, such as the strains of monkeypox prevalent in Central Africa, likely have the same ability.
   Similar news · Read more »
   
2. Scripps research team blocks bacterial communication system to prevent deadly staph infections
   10-30-2007 · EurekAlert!
   In hopes of combating the growing scourge of antibiotic-resistant bacteria, in particular drug-resistant staph bacteria, a team of scientists from The Scripps Research Institute has designed a new type of vaccine that could one day be used in humans to block the onset of infection.
   Similar news · Read more »
   
3. Influenza vaccine causes weaker immune response for children of rural Gabon than in semi-urban areas
   10-22-2007 · EurekAlert!
   Researchers have found that vaccination against influenza strains seem to be more effective in a semi-urban population than in a rural population of schoolchildren in Gabon, Africa, according to an article in the Journal of Infectious Diseases. The study is one of eight that will be presented and webcast live from the National Institutes of Health on Oct. 22, 2007 as part of the launch of the Council of Science Editors' Global Theme Issue on Poverty and Human Development.
   Similar news · Read more »
   
4. Edible food wrap kills deadly E. coli bacteria
   11-16-2006 · EurekAlert!
   Researchers have improved upon an edible coating for fresh fruits and vegetables by enabling it to kill deadly E. coli bacteria while also providing a flavor-boost to food. Composed of apple puree and oregano oil, which is a natural antibacterial agent, the coating shows promise in laboratory studies of becoming long-lasting alternative to conventional produce washes, according to a team of scientists from the US Department of Agriculture (USDA) and the University of Lleida in Spain.
   Similar news · Read more »
   
5. Antibody signal may redirect inflammation to fuel cancer
   02-19-2007 · EurekAlert!
   As evidence mounts that the body's normally protective inflammation response can drive some precancerous tissues to become fully malignant, UCSF scientists report discovering an apparent trigger to this potentially deadly process.
   Similar news · Read more »
   
6. Malaria vaccine trials begin using 'chimpanzee virus'
   01-31-2008 · EurekAlert!
   Trials are underway, funded by the Wellcome Trust, for a new vaccine to combat the most deadly form of malaria. For the first time ever, researchers will use a virus found in chimpanzees to boost the efficacy of the vaccine.
   Similar news · Read more »
   
7. Einstein researchers' prototype vaccine could provide improved protection against tuberculosis
   08-01-2007 · EurekAlert!
   Using a novel approach, researchers at the Albert Einstein College of Medicine of Yeshiva University have developed a prototype vaccine against tuberculosis, that works better in animal models than the only TB vaccine now available. In this era of multi-drug resistant TB and growing numbers of people with active TB due to coinfection with HIV, the advance could herald a needed breakthrough against one of the world's leading killers.
   Similar news · Read more »
   
8. Hib vaccine: A critical ally in Asia's effort to reduce child deaths
   06-28-2007 · EurekAlert!
   A new study shows Hib vaccine protects children from significant burden of life-threatening pneumonia and meningitis.The study shows Hib vaccine could prevent about one-third of life-threatening cases of bacterial pneumonia, the leading infectious cause of death in Asian children. Findings confirm burden of Hib pneumonia and meningitis grossly underestimated in Asia. More Asian countries are now planning introduction of Hib vaccine, while others still considering this option.
   Similar news · Read more »
   
9. First large-scale HIV vaccine trial in South Africa opens
   02-08-2007 · EurekAlert!
   A large-scale clinical trial of a candidate HIV vaccine -- which previously showed promise in smaller studies in the United States and elsewhere -- has now opened in South Africa. The study plans to enroll up to 3,000 HIV-negative men and women, making it the largest African HIV vaccine trial to date.
   Similar news · Read more »
   
10. Researchers discover new battleground for viruses and immune cells
    02-06-2008 · EurekAlert!
    Vaccines have led to many of the world's greatest public health triumphs, but many deadly viruses, such as HIV, still elude the best efforts of scientists to develop effective vaccines against them. An improved understanding of how the immune system operates during a viral infection is critical to designing successful anti-virus vaccines. Scientists from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, have added an important dimension to this knowledge.
    Similar news · Read more »